Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis.

Valenti L, Dongiovanni P, Maggioni M, Motta BM, Rametta R, Milano M, Fargion S, Reggiani P, Fracanzani AL.

J Hepatol. 2013 Feb;58(2):399-401. doi: 10.1016/j.jhep.2012.09.011. Epub 2012 Sep 19.

2.

Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.

Afzali A, Berry K, Ioannou GN.

Liver Transpl. 2012 Jan;18(1):29-37. doi: 10.1002/lt.22435.

3.

Obesity, fatty liver and liver cancer.

Qian Y, Fan JG.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):173-7. Review.

4.

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.

Hessheimer AJ, Forner A, Varela M, Bruix J.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1239-44. doi: 10.1097/MEG.0b013e32833aa19b.

PMID:
20505515
5.

Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.

Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, Cotler SJ, Fontana RJ, McCashland TM, Han SH, Gordon FD, Schilsky ML, Kowdley KV.

Liver Int. 2007 Dec;27(10):1394-401. Epub 2007 Oct 9.

PMID:
17927713
6.

[Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].

Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, Jang HJ, Lee JY, Park CH, Han TH, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK.

Korean J Gastroenterol. 2005 Jan;45(1):45-51. Korean.

7.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH.

Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.

PMID:
20975341
8.

Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Malik SM, Gupte PA, de Vera ME, Ahmad J.

Clin Gastroenterol Hepatol. 2009 Jul;7(7):800-6. doi: 10.1016/j.cgh.2009.02.025. Epub 2009 Mar 9.

PMID:
19281869
9.
10.

Obesity and hepatocellular carcinoma.

Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. Review.

PMID:
15508109
11.

Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.

Sikorska K, Romanowski T, Stalke P, Iżycka-Świeszewska E, Bielawski KP.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):270-5.

12.

NASH and HCC.

Page JM, Harrison SA.

Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007.

PMID:
19818310
13.

Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.

Ward SC, Chang CY, Peng L, Liu LU.

Semin Liver Dis. 2009 May;29(2):233-7. doi: 10.1055/s-0029-1216299. Epub 2009 Apr 22.

PMID:
19387922
14.

Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.

Serfaty L, Lemoine M.

Diabetes Metab. 2008 Dec;34(6 Pt 2):634-7. doi: 10.1016/S1262-3636(08)74597-X.

15.

Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.

Oya H, Sato Y, Yamamoto S, Nakatsuka H, Kobayashi T, Hara Y, Waguri N, Suda T, Aoyagi Y, Hatakeyama K.

Transplant Proc. 2006 Dec;38(10):3636-9.

PMID:
17175353
16.

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF.

World J Surg. 2011 Sep;35(9):2073-82. doi: 10.1007/s00268-011-1161-0.

PMID:
21656309
17.

Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?

Bellavance EC, Lumpkins KM, Mentha G, Marques HP, Capussotti L, Pulitano C, Majno P, Mira P, Rubbia-Brandt L, Ferrero A, Aldrighetti L, Cunningham S, Russolillo N, Philosophe B, Barroso E, Pawlik TM.

J Gastrointest Surg. 2008 Oct;12(10):1699-708. doi: 10.1007/s11605-008-0652-2. Epub 2008 Aug 15.

PMID:
18709418
18.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
19.

Hepatic resection for hepatocellular carcinoma in elderly patients.

Yeh CN, Lee WC, Jeng LB, Chen MF.

Hepatogastroenterology. 2004 Jan-Feb;51(55):219-23.

PMID:
15011868
20.

General evaluation of hepatectomy and hepatocellular carcinoma cases.

Başsüllü N, Türkmen I, Yaprak O, Dayangaç M, Demırbaş T, Güler N, Uraz S, Akyildiz M, Cığercıoğullari E, Tokat Y, Yüzer Y, Doğusoy GB.

Turk Patoloji Derg. 2011;27(3):221-9. doi: 10.5146/tjpath.2011.01079.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk